---
title: "PacBio director Christopher Smith resigns from board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292240396.md"
description: "Pacific Biosciences of California Inc. announced that director Christopher M. Smith resigned from the board, effective July 8, 2026. The company stated there were no disagreements with its operations, policies, or practices regarding his departure."
datetime: "2026-07-09T20:34:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292240396.md)
  - [en](https://longbridge.com/en/news/292240396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292240396.md)
generator: "portal-rs"
---

# PacBio director Christopher Smith resigns from board

-   Pacific Biosciences disclosed the resignation of director Christopher M. Smith, effective immediately on July 8, 2026. \* No disagreements with the company’s operations, policies, or practices were cited in connection with the departure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001299130-26-000111), on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PACB.US](https://longbridge.com/en/quote/PACB.US.md)

## Related News & Research

- [PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity](https://longbridge.com/en/news/296015220.md)
- [Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure](https://longbridge.com/en/news/295012410.md)
- [Pacific Biosciences of California (NASDAQ:PACB) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS](https://longbridge.com/en/news/295026820.md)
- [Canaccord Genuity Sticks to Their Buy Rating for Pacific Biosciences (PACB)](https://longbridge.com/en/news/295099834.md)
- [PacBio Q2 FY26 net loss widens to $44.7 million; revenue slips 2% to $39 million](https://longbridge.com/en/news/295013801.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**